SP/W-5186, a cysteine-containing nitric oxide donor, attenuates postischemic myocardial injury

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 2, 1998, Pages 527-537

  Liu, Gao Lin ^a   Christopher, Theodore A ^a   Lopez, Bernard L ^a   Gao, Feng ^a   Guo, Yaping ^a   Gao, Erhe ^a   Knuettel, Karlheinz ^b,c   Feelisch, Martin ^a,b,d   Ma, Xin L ^a,e  

^a Division of Emergency Medicine   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Schwarz Pharma AG   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE DERIVATIVE; N (3 NITRATOPIVALOYL) S (N' ACETYLGLYCYL)CYSTEINE ETHYL ESTER; NITRIC OXIDE; S (N ACETYLGLYCYL) N (3 NITRATOPIVALOYL)CYSTEINE ETHYL ESTER; SP W 6373; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; CELL ADHESION; CYSTEINE; DIPEPTIDES; HEART RATE; LIPID PEROXIDATION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHILS; NITRIC OXIDE DONORS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RABBITS;

EID: 0032462417     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bath PMW, Booth RFG and Hassall DG (1989) Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay. J Immunol Meth 118:59-65.
2. Born GVR (1962) Quantitative investigations into the aggregation of blood platelets. J Physiol 162:67P-78P.
3. Bowman PD, Betz AL and Goldstein GW (1982) Primary culture of microvascular endothelial cells from bovine retina: Selective growth using fibronectin coated substrate and plasma derived serum. In Vitro 18:626-632.
4. Bradley PP, Priebat DA, Christensen RD and Rothstein G (1982) Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209.
5. Colli S, Eligini S, Lalli M and Tremoli E (1996) Platelet-neutrophil interaction and superoxide anion generation: Involvement of purine nucleotides. Free Radical Biol Med 20:271-278.
6. Crow JP and Beckman JS (1996) The importance of superoxide in nitric oxide-dependent toxicity: Evidence for peroxynitrite-mediated injury. Adv Exp Med Biol 387:147-161.
7. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TBG Jr, Shin WS and Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68.
8. Diacovo TG, Roth SJ, Buccola JM, Bainton DF and Springer TA (1996) Neutrophil rolling, arrest and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood 88: 146-157.
9. Doerschuk CM, Allard MF and Hogg JC (1989) Neutrophil kinetics in rabbits during infusion of zymosan-activated plasma. J Appl Physiol 67:88-95.
10. Duncan CJ (1994) The role of oxygen radicals in ischaemia-reperfusion injury in the heart. Med Sci Res 22:609-611.
11. Duran WN, Silva A MB and Ferrante RJ (1994) Microcirculatory dysfunction in ischemia: reperfusion injury. In: Reperfusion Injuries and Clinical Capillary Leak Syndrome, ed. by B. A. Zikria, M. O. Oz and R. W. Carlson, pp. 145-169, Futura Publishing Company, Inc., Armonk, New York.
12. Egdell RM, Siminiak T and Sheridan DJ (1994) Modulation of neutrophil activity by nitric oxide during acute myocardial ischaemia and reperfusion. Basic Res Cardiol 89:499-509.
13. Engelman DT, Watanabe M, Maulik N, Cordis GA, Engelman M, Rousou JA, Flack JE III, Deaton DW and Das DK (1995) L-Arginine reduces endothelial inflammation and myocardial stunning during ischemia reperfusion. Ann Thorac Surg 60:1275-1281.
14. Flaherty JT (1989) Nitrate tolerance: A review of the evidence. Drugs 37:523-550.
15. Gauthier TW, Davenpeck KL and Lefer AM (1994) Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol Gastrointest. Liver Physiol 267:G562-G568.
16. Hansen PR (1995) Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91:1872-1885.
17. Kern PA, Knedler A and Eckel RH (1983) Isolation and culture of microvascular endothelium from human adipose tissue. J Clin Invest 71:1822-1829.
18. Kilgore KS and Lucchesi BR (1993) Reperfusion injury after myocardial infarction: The role of free radicals and the inflammatory response. Clin Biochem 26:359-370.
19. Koijda G, Feelisch M and Noack E (1995) Sulfhydryl-containing nitrate esters: A new class of nitric oxide donors. Cardiovasc Drug Rev 13:275-288.
20. Laskey RE and Mathews WR (1996) Nitric oxide inhibits peroxynitrite-induced production of hydroxyeicosatetraenoic acids and F2-isoprostanes in phosphatidylcholine liposomes. Arch Biochem Biophys 330:193-198.
21. Lefer AM, Tsao PS, Lefer DJ and Ma XL (1991) Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 5:2029-2034.
22. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J and Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632.
23. Lucchesi BR (1994) Cardiac reperfusion injury. In: Reperfusion Injury and Clinical capillary Leak Syndrome, ed. by B. A. Zikria, M. O. Oz and R. W. Carlson, pp. 171-202, Futura Publishing Company, Inc., Armonk, New York.
24. Ma XL, Weyrich AS, Lefer DJ and Lefer AM (1993) Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 72:403-412.
25. Ma XL, Yue TL, Lopez BL, Barone FC, Christopher TA, Ruffolo RR Jr and Feuerstein GZ (1996) Carvedilol, a new beta-adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits. J Pharmacol Exp Ther 277:128-136.
26. Maxwell SRJ and Lip GYH (1997) Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 58:95-117.
27. Maynard C, Weaver WD, Litwin PE, Martin JS, Kudenchuk PJ, Dewhurst TA, Eisenberg MS, Hallstrom AP and Chambers J (1993) Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention Project). Am J Cardiol 72:877-882.
28. Moncada S and Higgs EA (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319-1330.
29. Mullane KM, Kraemer R and Smith B (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Meth 14:157-167.
30. Nash GB (1994) Adhesion between neutrophils and platelets: A modulator of thrombotic and inflammatory events?. Thromb Res 74 Suppl 1:S3-11.
31. Needleman P, Jakschik B and Johnson EM Jr (1973) Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Therap 187:324-331.
32. Ohkawa H, Ohishi N and Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358.
33. Pietersma A, De Jong N, Koster JF and Sluiter W (1994) Effect of hypoxia on adherence of granulocytes to endothelial cells in vitro. Am J Physiol 267:H874-H879.
34. Provost P, Lam JYT, Lacoste L, Merhi Y and Waters D (1994) Endothelium-derived nitric oxide attenuates neutrophil adhesion to endothelium under arterial flow conditions. Arterioscler Thromb 14:331-335.
35. Renzi PM and Flynn JT (1992) Endotoxin enhances arachidonic acid metabolism by cultured rabbit microvascular endothelial cells. Am J Physiol 263:H1213-H1221.
36. Rosalki SB (1967) An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 69:697-705.
37. Sato H, Zhao ZQ, McGee DS, Williams MW, Hammon JW Jr and Vinten-Johansen J (1995) Supplemental T-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg 110:302-314.
38. Stamler JS and Loscalzo J (1991) The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relavance to cardiovascular disorders. J Am Coll Cardiol 8:1529-1536.
39. Todd J, Zhao ZQ, Williams MW, Sato H, Van Wylen DGL and Vinten-Johansen J (1996) Intravascular adenosine at reperfusion reduces infarct size and neutrophil adherence. Ann Thorac Surg 62:1364-1372.
40. Weyrich AS, Ma XL and Lefer AM (1992) The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86:279-288.
41. Yang BC and Mehta JL (1997) Inhibition of nitric oxide does not affect reperfusion-induced myocardial injury, but it prevents lipid peroxidation in the isolated rat heart. Life Sci 61:229-236.